During Treatment

FIELD PRACTICE BASIS: Dickinson et al. (GITA, 2016), Lotsof & Wachtel historical manual, Wells provider notes, Rocha et al. (2023), and monitored human ibogaine studies. The practical recommendations above are retained where they are low risk, reversible, participant centered, and compatible with current medical care. Outdated community medication, dosing, electrolyte, or monitoring rules are not imported wholesale.

The same supportive action can be appropriate at one point in the session and disruptive at another. Use the sequence below as an operational rhythm rather than a rigid clock. The participant’s physiology, level of impairment, preferences, and clinical trajectory determine when the team moves from one phase to the next.

FIELD PRACTICE NOTE: This sequence organizes existing clinical evidence and field-practice content into a usable bedside workflow. It is not a validated timing protocol and should not be used to override patient-specific clinical judgment.

Small details can change the room. Multiple staff members whispering near the bed, bright overhead light, a television, phones, an unfamiliar person entering without introduction, sudden repositioning, strong incense, or repeatedly asking the participant to describe what they are seeing can become disproportionately intrusive. A quieter setup is often better: one lead voice, predictable introductions, low traffic, a room that can be darkened without compromising observation, and enough restraint from the team to let the participant have an internal experience without performing it for staff.

When the participant becomes suspicious of caregivers or interprets ordinary actions as hostile, reduce the number of voices, avoid crowding, explain medical actions plainly, keep movements slow, and do not argue about the literal truth of the perception. Preserve ordinary choice wherever possible. If the change is accompanied by worsening orientation, dangerous behavior, severe agitation, sleep-deprived activation, hypoxia, abnormal vital signs, or another medical concern, the clinical differential takes priority over the psychedelic narrative.

A real-world tool should not force practitioners to choose between “evidence based” and “experienced based” care when the source types are answering different questions. Cardiology should determine how an unstable rhythm is handled. Toxicology should guide a dangerous interaction. Addiction medicine should guide withdrawal and ongoing treatment. Experienced ibogaine practice can still teach the team to put the emesis basin within reach before the person becomes unable to sit up, to plan bathroom assistance before ataxia peaks, to avoid unnecessary conversation during deep inward absorption, to arrange shifts before anyone is exhausted, and to understand that a person can be physically helpless while mentally aware. Those are different kinds of knowledge, and the resource should preserve both.

The facilitator’s job is to make the experience physically and relationally safer without taking over its meaning. That includes knowing when not to move the participant, when to reduce stimulation, how to explain care before touching, how to preserve privacy during vomiting or toileting, and how to recognize when a difficult experience is becoming a medical or psychiatric problem. The person can be profoundly impaired in coordination and still remain aware of how they are being treated.

Published phenomenology is much broader than the stereotyped “visionary journey.” Heink et al. found altered perception, autobiographical insight, and wide variation in visual experience. Brown, Noller, and Denenberg described oneiric material involving repeating imagery, remorse, guilt, relationships, release, and spiritual themes. Kohek et al. identified physical, sensory, visual, cognitive, auditory, adverse, anti dependency, and after effect categories, including ancestors or entities, landscapes, and horrific scenarios. The 2025 Ibogaine Experience Scale, developed in 499 participants, captured seven dimensions spanning symbolic visions, visual change, discomfort and challenge, archetypal or cosmic content, introspection, somatosensory activation, and dissociation.

The closest established clinical language is acute paranoid or persecutory ideation, but the caregiver centered presentation described in ibogaine practice does not appear to have a standardized diagnostic name. This lens therefore uses Transient Persecutory Mistrust as descriptive project language for a temporary state in which ordinary monitoring, staff conversations, touch, redirection, or necessary medical care are interpreted as deceptive, controlling, or threatening. It is not a diagnosis and does not establish psychosis by itself. Broader psychedelic literature describes paranoid psychotic reactions in a subset of acutely distressing experiences and recognizes perceived threat as part of some traumatic psychedelic experiences (Bröcker et al., 2026; Calder et al., 2026).

When this develops, reduce avoidable staff traffic and side conversations, use one calm lead voice, explain actions before taking them, preserve choices where safety allows, and avoid arguing about the content of the belief. The facilitator should stay curious about what the participant is perceiving while the clinical team continues to assess oxygenation, rhythm, withdrawal, delirium, medication effects, sleep loss, mania, psychosis, and other causes of an abrupt change in interpretation. The trajectory matters. Brief mistrust that softens as stimulation drops is different from increasingly fixed persecutory beliefs, disorganization, grandiosity, threats, or loss of behavioral control.

Relational response: simplify the room. One calm person speaks. Give the participant physical space, explain what you are doing before you do it, and offer choices whenever safety allows. If another staff member feels safer to the participant, let that person take the lead. Avoid crowding, arguing, matching hostility, or turning the team into an audience. Keep assessing for delirium, seizure, hypoxia, arrhythmia, withdrawal, and emerging psychiatric danger at the same time.

Intense visionary material does not automatically require interpretation, confrontation, or deeper immersion. Ibogaine's visual phenomena are often strongest with the eyes closed, and a peer-reviewed description of the ibogaine medical subculture notes that these internally represented visual phenomena tend to be suppressed when the eyes are opened (Alper et al., 2008). Historical provider guidance describes the same practical observation. Hattie Wells also described the effect in a 2022 public interview, and the Sacred Warrior Community participant workbook separately teaches opening the eyes as an optional break from closed-eye visuals and a way to reorient to the body. This gives facilitators a simple, low-complexity orientation option when the participant wants less immersion: invite the person to open the eyes, orient to the room, reduce sensory isolation, and re-establish ordinary contact without insisting that they remain inside overwhelming imagery.

A participant asking for the experience to become less intense should not be told that distress must be endured because the medicine is supposedly forcing necessary material. First determine whether the problem is primarily visionary intensity, sensory overload, relational fear, panic, delirium, mania, psychosis, hypoxia, syncope, arrhythmia, withdrawal, or another medical change. When the person remains medically and psychiatrically stable, supportive grounding may include one calm voice, opening the eyes, gentle orientation to place and time, reducing unnecessary noise or darkness, changing the sensory environment, and offering previously consented grounding contact if the participant wants it. None of these measures should be represented as guaranteed to terminate the oneirogenic state.

Word of mouth from indigenous iboga practice describes offering banana when visions become too intense, with the intention of reducing the visions. If offered, explain its purpose and respect the participant’s choice. Check that the person is alert enough to swallow safely and that eating fits the care plan.

Related contemporary accounts describe a similar purpose. In an interview with Nick Urban, Jeff McNairy describes bananas being used to help people come down from the intensity of iboga (38:51). An online community account by Entheobirth describes retreats offering bananas after a session to temper lingering effects. These are practitioner and community accounts.

Eye opening as a way of reducing closed eye visual phenomena is described by Alper et al. (2008), historical provider guidance, Hattie Wells’ 2022 practitioner interview, and separately a Sacred Warrior Community participant workbook. Offer it according to the participant’s preference and response.

Severe ataxia is not a side note to the experience. In the Knuijver cohort, every participant developed clinically evident cerebellar ataxia and could not walk unsupported at peak effect. Luciano’s peer reviewed clinical observation described transient vestibulocerebellar dysfunction with nystagmus, intention tremor, gait ataxia, and prominent movement induced nausea and vomiting. These data fit the practical observation that a person can feel relatively settled while lying still and become abruptly nauseated or vertiginous when asked to sit, stand, turn the head, or walk (Knuijver et al., 2022; Luciano, 1998).

General vestibular physiology provides a plausible explanation. Vestibular and gastrointestinal emetic signals converge in brainstem and cerebellar networks involved in motion sickness and vomiting (Yates et al., 2014). That does not prove that all ibogaine nausea is vestibular. Drug effect, withdrawal, gastrointestinal illness, anxiety, coexposures, dehydration, and other causes remain possible. It does support treating movement as a modifiable symptom trigger when the participant is otherwise medically stable.

Practical support is simple: do not make the person move merely because it is convenient for staff. Keep necessary objects within reach. Cluster examinations and care when possible. Explain a position change before it happens, move slowly, pause when nausea or vertigo rises, and use enough assistance that the participant is not balancing independently. If the participant needs the bathroom, plan the route and the number of people required before standing. When the clinical question can be answered safely in bed, do not turn ambulation into a test of cooperation.

Movement minimization is supportive care, not a reason to skip a necessary neurological examination, delay an ECG, or ignore a new focal finding. Persistent or asymmetric vertigo, focal neurological deficits, worsening consciousness, unusual nystagmus, severe headache, recurrent syncope, or a course that does not fit expected recovery deserves medical evaluation.

The body can become profoundly dependent even while awareness is intact. In Knuijver’s safety cohort, all 14 participants developed measurable cerebellar ataxia, most strongly two to six hours after administration. Several still had residual signs at 24 hours, and nursing assistance was needed for bathroom trips. Vomiting also occurred and is reported across the broader literature. From the participant’s side, that can feel strange and vulnerable: the mind may be clear enough to know what is happening while the legs, balance, and coordination no longer feel reliable.

Participants may use “dizzy” for several different experiences. The distinction matters because the practical response and the differential are not identical. Ask what the sensation actually feels like before assuming it is the expected ibogaine vestibulocerebellar effect.

PRACTICE NOTE: Movement-provoked nausea is documented in human ibogaine observation, and vestibular physiology provides a plausible mechanism. It should be treated as one common pattern, not the only explanation for nausea, dizziness, or vomiting.

Long sessions create ordinary care needs that become easy to underestimate when attention is focused on the visionary process. A participant may remain in one position for hours, become sore, need help urinating, feel cold or overheated, have dry mouth, struggle to eat, or be unable to sleep despite exhaustion. None of those problems is glamorous, but they shape the safety and memory of the experience.

Plan rather than improvise. Keep bedding and clothing easy to adjust. Reassess comfort and positioning without creating unnecessary motion. Offer toileting support that preserves privacy. Track intake, urine, vomiting, and hydration when clinically relevant. Once nausea is settling and swallowing is safe, reintroduce fluids and simple food based on tolerance and the participant’s medical needs rather than forcing a large meal.

Word of mouth from indigenous iboga practice describes offering banana when visions become too intense, with the intention of reducing the visions. During recovery, food choices can follow appetite, tolerance, and preference. Clinical treatment of dehydration or an electrolyte deficit should follow the medical assessment.

Sleep needs explicit attention during recovery. Ibogaine can be followed by prolonged wakefulness, and sleep loss can blur the line between normal post acute activation and emerging psychiatric instability. Track sleep as a vital part of the psychiatric trajectory, not merely an inconvenience.

People may describe deceased relatives, entities, moral judgment, spiritual instruction, ancestral material, cosmic scenes, or an experience of death and rebirth. Stay curious and let the participant own the meaning. Questions such as “What was that like for you?” “What did it mean to you?” and “Do you want to stay with it, or would more orientation help right now?” leave room for the experience without turning the clinician’s belief system into part of the treatment.

EVIDENCE NOTE: phenomenology studies describe reported subjective experience. The 2025 IES is a validated measure of subjective effects; its factors are measurement domains rather than diagnostic categories or a template for what every person should experience.

EVIDENCE STATUS: Controlled studies and the pattern of serious adverse events support structured medical staffing and monitoring. The literature does not define an evidence based staffing ratio, so ratios still depend on jurisdiction, facility capability, and patient acuity.

NAMED CONTEMPORARY PROGRAM EXAMPLE: Beond’s public practitioner materials describe nursing preparation that combines ACLS, cardiac monitoring, and altered-state support, along with trauma-informed intake and individualized consent. The program also reports assigning emergency roles before a shift begins, including team leadership, airway, compressions, defibrillation, medications, and event recording. The transferable practice point is role clarity, rehearsal, and readiness before a crisis; Beond’s exact staffing pattern is not a universal ibogaine requirement.

The person closest to the participant needs more than rhythm recognition. They need to stay calm, observant, noncoercive, and relationally steady while unusual or frightening material unfolds. General psychedelic therapy literature emphasizes trust, empathy, self awareness, and presence. Ibogaine adds a second demand: the same team must stay medically attentive and be ready to escalate when the clinical picture changes.

Ibogaine sessions are long enough for staff fatigue to become a safety issue. Build the schedule around shifts, clean handoffs, closed-loop communication, and a shared record of ECG trajectory, symptoms, medications, fluid losses, mobility, mental status, and unresolved concerns. Any team member should be able to raise a safety concern immediately, regardless of seniority or ceremonial authority. Historical provider notes reinforce the operational point: Wells described remaining continuously present through very long sessions, later concluding that solo coverage was unsustainable and that future treatments should use shifts and continuous presence rather than depending on one exhausted attendant. The lesson is not to copy one provider’s schedule. It is to treat fatigue and coverage as predictable safety variables.

Ibogaine programs frequently include people whose expertise comes from medicine, nursing, psychotherapy, addiction recovery, ceremonial practice, apprenticeship, personal treatment experience, or some combination. Those backgrounds can be valuable, but none should be allowed to stand in for competencies the person does not actually hold. Participants should know who is doing what and why.

Enginsoy’s 2025 provider interviews found that many practitioners entered the field through their own substance-use, mental-health, or ibogaine experiences. That “wounded healer” pattern can support empathy and credibility, but it strengthens rather than removes the need for reflexivity, boundaries, supervision, and explicit role limits.

NAMED CONTEMPORARY PROVIDER COMMENTARY: Michael Higgs described beginning at The Mission Within with practical support such as transportation, dishes, towels, and helping participants to the bathroom. He also described recognizing that he had moved into helping too quickly before completing enough of his own work, stepping back, and later completing integration-coaching training before taking on a larger coaching and facilitation role. This is field commentary rather than a credentialing standard, but it gives a concrete example of role maturation, reflexivity, and the difference between lived experience and demonstrated readiness.

Some contemporary programs deliberately carry a support relationship across more than one phase of care. Beond publicly describes preparation and integration coaching that begins before arrival, continues onsite, and extends after the participant returns home. The operational value is continuity of history, trust, expectations, and follow-up ownership. The Mission Within has separately described preparation coaching before treatment and integration coaching afterward. These are named program models, not evidence that one continuity structure produces superior outcomes.

Before each treatment period, check that injectable magnesium, the selected seizure rescue benzodiazepine, bradycardia medications, fluid and electrolyte replacement supplies, and the selected antiemetic are accessible with written orders. Confirm the defibrillator and pacing functions, suction, ventilation equipment, IV supplies, and transfer contact. Assign responsibility for expiry checks, restocking, and repeat dose availability. The medication reference gives the indication and monitoring detail for each group.

Design the medical environment and the lived experience together. The room should allow privacy, quiet, physical comfort, staff observation, alarm audibility, and fast emergency access at the same time. The participant should feel cared for while the team still has room to work if the session suddenly becomes medical.

Historical GITA minimal standards emphasized basic environmental hazards such as bathroom slips, emergency exits, handwashing, sharps, equipment maintenance, and fire planning. Those details remain relevant because many preventable failures occur outside the ECG trace. Local facility codes and health-care regulations take precedence where they apply.

Practice note: no single monitoring schedule has been validated across all formulations and patient types. Use the Knuijver protocol as a published benchmark and make the local schedule responsive to QT, rhythm, symptoms, and overall clinical change.

Ibogaine is not primarily a respiratory depressant in the way opioids or sedative hypnotics are, but the population receiving it often brings respiratory risk into the room. Recent opioid or sedative exposure, repeated vomiting, impaired coordination, reduced consciousness, aspiration, seizure, and rescue medications can all change airway safety. A quiet participant with an inward focus still requires observation of breathing and the ability to protect the airway when clinical context makes that concern relevant.

Respiratory support should be proportionate to the person and the exposure. Observe respiratory rate and effort, positioning, consciousness, emesis, and oxygenation when indicated. Pulse oximetry is useful when opioid or sedative coexposure, aspiration, hypoxia, or other respiratory concern is present. Capnography can be appropriate when clinically significant sedation or respiratory depression is a concern and the setting is equipped to interpret it. Neither tool replaces direct observation.

Vomiting changes the problem when the person cannot reposition independently, cannot protect the airway, becomes progressively sedated, develops hypoxia, or has abnormal lung findings. The facilitator should know how to summon medical help immediately and should not interpret coughing, hypoxia, or reduced responsiveness as part of the psychological process.